Project Number 1R01AG061091-01 Agency/Funding Organization NIA Funding Year 2018 View Full Project Details for A PHASE 3 PIVOTAL TRIAL OF AGB101 TO SLOW PROGRESSION IN MCI DUE TO ALZHEIMER'S DISEASE Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 8. Late-stage Clinical Drug Development (Phase II/III and III Clinical Trials) m. Synaptic Plasticity/Neuroprotection Researcher and Organization Principal Investigator MOHS, RICHARD CHARLES Principal Investigator First Name RICHARD CHARLES Principal Investigator Last Name MOHS Awardee Organization AGENEBIO, INC. Awardee State Maryland Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-028: Phase III Clinical Trials for the Spectrum of Alzheimer's Disease and Age-related Cognitive Decline (R01 Clinical Trial Required) FY Overall Cost $4,951,060 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M
